Compare $CELZ vs $XBIO | Chartloom

Compare

$CELZ vs $XBIO

Creative Medical Technology Holdings Inc · Xenetic Biosciences Inc

CELZ

Creative Medical Technology Holdings Inc

XBIO

Xenetic Biosciences Inc

Compare $CELZ vs $XBIO

Comparing Creative Medical Technology Holdings Inc and Xenetic Biosciences Inc

CELZCreative Medical Technology Holdings Inc

XBIOXenetic Biosciences Inc

CELZCreative Medical Technology Holdings Inc

Market cap

$4M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-50.0%

YTD performance

-57.4%

52W performance

-76.5%

FCF yield

-148.5%

XBIOXenetic Biosciences Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

33.3%

YTD performance

-0.9%

52W performance

-79.4%

FCF yield

-47.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CELZ

XBIO

Detailed metrics comparison

CELZ

Creative Medical Technology Holdings Inc

XBIO

Xenetic Biosciences Inc

Market Cap

CELZ$4M

XBIO$5M

Enterprise Value

CELZ$-5M

XBIO$-2M

Price

CELZ$0.84

XBIO$2.13

P/E Ratio

CELZN/A

XBION/A

P/S Ratio

CELZ1,324.83x

XBIO1.50x

EV/Sales

CELZ-1,579.87x

XBIO-0.49x

EV/EBITDA

CELZ0.00x

XBIO0.00x

P/B Ratio

CELZ0.72x

XBIO0.81x

P/FCF Ratio

CELZN/A

XBION/A

EV/FCF

CELZ0.80x

XBIO0.69x

PEG Ratio

CELZN/A

XBION/A

Forward P/E (NTM)

CELZN/A

XBION/A

Forward P/S (NTM)

CELZN/A

XBION/A

Revenue (TTM)

CELZ$3K

XBIO$3M

Revenue Growth (YoY)

CELZ-50.0%

XBIO33.3%

Forward Rev Growth

CELZ56.2%

XBIO-16.7%

Gross Margin (TTM)

CELZ66.7%

XBIO98.7%

Operating Margin (TTM)

CELZ0.0%

XBIO0.0%

EBITDA Margin (TTM)

CELZ-204213.3%

XBIO-81.0%

Net Margin (TTM)

CELZ-201356.7%

XBIO-75.9%

FCF Margin (TTM)

CELZ-196726.7%

XBIO-70.9%

Net Income (TTM)

CELZ$-6M

XBIO$-2M

FCF (TTM)

CELZ$-6M

XBIO$-2M

EPS (TTM)

CELZ-$1.63

XBIO-$1.08

ROE (TTM)

CELZ-8670.0%

XBIO-4062.0%

ROA (TTM)

CELZ-8196.0%

XBIO-3497.0%

ROIC (TTM)

CELZ-8670.0%

XBIO-4062.0%

Cash

CELZ$9M

XBIO$6M

Debt

CELZ$0

XBIO$0

Net Cash/Debt

CELZ$9M

XBIO$6M

Current Ratio (TTM)

CELZ12.91x

XBIO7.43x

Quick Ratio (TTM)

CELZ12.63x

XBIO7.23x

Debt/Equity (TTM)

CELZ0.00x

XBIO0.00x

Debt/Assets (TTM)

CELZ0.0%

XBIO0.0%

Interest Coverage (TTM)

CELZN/A

XBION/A

Net Debt/EBITDA (TTM)

CELZ0.00x

XBIO0.00x

Beta

CELZ1.93

XBIO2.36

52W Performance

CELZ-76.5%

XBIO-79.4%

YTD Performance

CELZ-57.4%

XBIO-0.9%

% from 52W High

CELZ-86.6%

XBIO-79.2%

% from 52W Low

CELZ35.2%

XBIO13.9%

Asset Turnover (TTM)

CELZ0.00x

XBIO0.46x

FCF Yield (TTM)

CELZ-148.5%

XBIO-47.4%

Earnings Yield (TTM)

CELZ-152.0%

XBIO-50.7%

Dividend Yield (TTM)

CELZN/A

XBION/A

Rule of 40

CELZ-196,776.7

XBIO-37.6

EV/GP/RG

CELZN/A

XBION/A

Ticker research

View CELZ research View XBIO research

Metric	CELZ Creative Medical Technology Holdings Inc	XBIO Xenetic Biosciences Inc
Market & Valuation
Market Cap	$4M	$5M
Enterprise Value	$-5M	$-2M
Price	$0.84	$2.13
P/E Ratio	N/A	N/A
P/S Ratio	1,324.83x	1.50x
EV/Sales	-1,579.87x	-0.49x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.72x	0.81x
P/FCF Ratio	N/A	N/A
EV/FCF	0.80x	0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$3K	$3M
Revenue Growth (YoY)	-50.0%	33.3%
Forward Rev Growth	56.2%	-16.7%
Profitability
Gross Margin (TTM)	66.7%	98.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-204213.3%	-81.0%
Net Margin (TTM)	-201356.7%	-75.9%
FCF Margin (TTM)	-196726.7%	-70.9%
Net Income (TTM)	$-6M	$-2M
FCF (TTM)	$-6M	$-2M
EPS (TTM)	-$1.63	-$1.08
ROE (TTM)	-8670.0%	-4062.0%
ROA (TTM)	-8196.0%	-3497.0%
ROIC (TTM)	-8670.0%	-4062.0%
Financial Health
Cash	$9M	$6M
Debt	$0	$0
Net Cash/Debt	$9M	$6M
Current Ratio (TTM)	12.91x	7.43x
Quick Ratio (TTM)	12.63x	7.23x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.93	2.36
52W Performance	-76.5%	-79.4%
YTD Performance	-57.4%	-0.9%
% from 52W High	-86.6%	-79.2%
% from 52W Low	35.2%	13.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.46x
FCF Yield (TTM)	-148.5%	-47.4%
Earnings Yield (TTM)	-152.0%	-50.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-196,776.7	-37.6
EV/GP/RG	N/A	N/A
Ticker research	View CELZ research	View XBIO research

Valuation

P/S Ratio

XBIO

1.50x

CELZ

1,324.83x

EV/FCF

XBIO

0.69x

CELZ

0.80x

Growth & revenue

Revenue Growth TTM

XBIO

33.3%

CELZ

-50.0%

Forward Revenue Growth

CELZ

56.2%

XBIO

-16.7%

Profitability & performance

Gross Margin

XBIO

98.7%

CELZ

66.7%

ROE

XBIO

-4062.0%

CELZ

-8670.0%

FCF Yield %

XBIO

-47.4%

CELZ

-148.5%

52-Week Performance

CELZ

-76.5%

XBIO

-79.4%

Detailed metrics comparison

CELZ

Creative Medical Technology Holdings Inc

XBIO

Xenetic Biosciences Inc

Market Cap

CELZ$4M

XBIO$5M

Enterprise Value

CELZ$-5M

XBIO$-2M

Price

CELZ$0.84

XBIO$2.13

P/E Ratio

CELZN/A

XBION/A

P/S Ratio

CELZ1,324.83x

XBIO1.50x

EV/Sales

CELZ-1,579.87x

XBIO-0.49x

EV/EBITDA

CELZ0.00x

XBIO0.00x

P/B Ratio

CELZ0.72x

XBIO0.81x

P/FCF Ratio

CELZN/A

XBION/A

EV/FCF

CELZ0.80x

XBIO0.69x

PEG Ratio

CELZN/A

XBION/A

Forward P/E (NTM)

CELZN/A

XBION/A

Forward P/S (NTM)

CELZN/A

XBION/A

Revenue (TTM)

CELZ$3K

XBIO$3M

Revenue Growth (YoY)

CELZ-50.0%

XBIO33.3%

Forward Rev Growth

CELZ56.2%

XBIO-16.7%

Gross Margin (TTM)

CELZ66.7%

XBIO98.7%

Operating Margin (TTM)

CELZ0.0%

XBIO0.0%

EBITDA Margin (TTM)

CELZ-204213.3%

XBIO-81.0%

Net Margin (TTM)

CELZ-201356.7%

XBIO-75.9%

FCF Margin (TTM)

CELZ-196726.7%

XBIO-70.9%

Net Income (TTM)

CELZ$-6M

XBIO$-2M

FCF (TTM)

CELZ$-6M

XBIO$-2M

EPS (TTM)

CELZ-$1.63

XBIO-$1.08

ROE (TTM)

CELZ-8670.0%

XBIO-4062.0%

ROA (TTM)

CELZ-8196.0%

XBIO-3497.0%

ROIC (TTM)

CELZ-8670.0%

XBIO-4062.0%

Cash

CELZ$9M

XBIO$6M

Debt

CELZ$0

XBIO$0

Net Cash/Debt

CELZ$9M

XBIO$6M

Current Ratio (TTM)

CELZ12.91x

XBIO7.43x

Quick Ratio (TTM)

CELZ12.63x

XBIO7.23x

Debt/Equity (TTM)

CELZ0.00x

XBIO0.00x

Debt/Assets (TTM)

CELZ0.0%

XBIO0.0%

Interest Coverage (TTM)

CELZN/A

XBION/A

Net Debt/EBITDA (TTM)

CELZ0.00x

XBIO0.00x

Beta

CELZ1.93

XBIO2.36

52W Performance

CELZ-76.5%

XBIO-79.4%

YTD Performance

CELZ-57.4%

XBIO-0.9%

% from 52W High

CELZ-86.6%

XBIO-79.2%

% from 52W Low

CELZ35.2%

XBIO13.9%

Asset Turnover (TTM)

CELZ0.00x

XBIO0.46x

FCF Yield (TTM)

CELZ-148.5%

XBIO-47.4%

Earnings Yield (TTM)

CELZ-152.0%

XBIO-50.7%

Dividend Yield (TTM)

CELZN/A

XBION/A

Rule of 40

CELZ-196,776.7

XBIO-37.6

EV/GP/RG

CELZN/A

XBION/A

Ticker research

View CELZ research View XBIO research

Metric	CELZ Creative Medical Technology Holdings Inc	XBIO Xenetic Biosciences Inc
Market & Valuation
Market Cap	$4M	$5M
Enterprise Value	$-5M	$-2M
Price	$0.84	$2.13
P/E Ratio	N/A	N/A
P/S Ratio	1,324.83x	1.50x
EV/Sales	-1,579.87x	-0.49x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.72x	0.81x
P/FCF Ratio	N/A	N/A
EV/FCF	0.80x	0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$3K	$3M
Revenue Growth (YoY)	-50.0%	33.3%
Forward Rev Growth	56.2%	-16.7%
Profitability
Gross Margin (TTM)	66.7%	98.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-204213.3%	-81.0%
Net Margin (TTM)	-201356.7%	-75.9%
FCF Margin (TTM)	-196726.7%	-70.9%
Net Income (TTM)	$-6M	$-2M
FCF (TTM)	$-6M	$-2M
EPS (TTM)	-$1.63	-$1.08
ROE (TTM)	-8670.0%	-4062.0%
ROA (TTM)	-8196.0%	-3497.0%
ROIC (TTM)	-8670.0%	-4062.0%
Financial Health
Cash	$9M	$6M
Debt	$0	$0
Net Cash/Debt	$9M	$6M
Current Ratio (TTM)	12.91x	7.43x
Quick Ratio (TTM)	12.63x	7.23x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.93	2.36
52W Performance	-76.5%	-79.4%
YTD Performance	-57.4%	-0.9%
% from 52W High	-86.6%	-79.2%
% from 52W Low	35.2%	13.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.46x
FCF Yield (TTM)	-148.5%	-47.4%
Earnings Yield (TTM)	-152.0%	-50.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-196,776.7	-37.6
EV/GP/RG	N/A	N/A
Ticker research	View CELZ research	View XBIO research